Nan Fung Group Holdings LTD Madrigal Pharmaceuticals, Inc. Transaction History
Nan Fung Group Holdings LTD
- $103 Million
- Q3 2024
A detailed history of Nan Fung Group Holdings LTD transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Nan Fung Group Holdings LTD holds 9,762 shares of MDGL stock, worth $2.82 Million. This represents 2.02% of its overall portfolio holdings.
Number of Shares
9,762
Previous 5,682
71.81%
Holding current value
$2.82 Million
Previous $1.59 Million
30.17%
% of portfolio
2.02%
Previous 1.85%
Shares
4 transactions
Others Institutions Holding MDGL
# of Institutions
296Shares Held
22MCall Options Held
819KPut Options Held
640K-
Janus Henderson Group PLC London, X02.48MShares$715 Million0.28% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny2.04MShares$589 Million29.57% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.03MShares$586 Million6.48% of portfolio
-
Rtw Investments, LP New York, NY1.99MShares$575 Million6.74% of portfolio
-
Baker Bros. Advisors LP New York, NY1.97MShares$570 Million4.49% of portfolio
About MADRIGAL PHARMACEUTICALS, INC.
- Ticker MDGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,103,400
- Market Cap $4.94B
- Description
- Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...